BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yeh MM, Yeung RS, Apisarnthanarax S, Bhattacharya R, Cuevas C, Harris WP, Hon TLK, Padia SA, Park JO, Riggle KM, Daoud SS. Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience. World J Hepatol 2015; 7(11): 1460-1483 [PMID: 26085907 DOI: 10.4254/wjh.v7.i11.1460]
URL: https://www.wjgnet.com/1007-9327/full/v7/i11/1460.htm
Number Citing Articles
1
Chengping Zhang, Muhammad Faisal Buland Iqbal, Imran Iqbal, Minghao Cheng, Nadia Sarhan, Emad Mahrous Awwad, Yazeed Yasin Ghadi. Prognostic Modeling for Liver Cirrhosis Mortality Prediction and Real-Time Health Monitoring from Electronic Health DataBig Data 2024;  doi: 10.1089/big.2024.0071
2
Sang Bu An, Kwangmo Yang, Chang Won Kim, Si Ho Choi, Eunji Kim, Sung Dae Kim, Jae Soo Koh. Longitudinal Imaging of Liver Cancer Using MicroCT and Nanoparticle Contrast Agents in CRISPR/Cas9-Induced Liver Cancer Mouse ModelTechnology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211016466
3
Jong Man Kim, Jinsoo Rhu, Sang Yun Ha, Gyu-Seong Choi, Choon Hyuck David Kwon, Gaabsoo Kim, Jae-Won Joh. Realization of improved outcomes following liver resection in hepatocellular carcinoma patients aged 75 years and olderAnnals of Surgical Treatment and Research 2021; 101(5): 257 doi: 10.4174/astr.2021.101.5.257
4
Matthew M. Yeh, Yajuan Liu, Michael Torbenson. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic studyHuman Pathology 2015; 46(11): 1769 doi: 10.1016/j.humpath.2015.07.018
5
Hae Won Lee, Kyung-Suk Suh. Expansion of the criteria for living donor liver transplantation for hepatocellular carcinomaCurrent Opinion in Organ Transplantation 2016; 21(2): 231 doi: 10.1097/MOT.0000000000000294
6
Matthew M. Yeh, Sarag Boukhar, Benjamin Roberts, Nairanjana Dasgupta, Sayed S. Daoud. Genomic variants link to hepatitis C racial disparitiesOncotarget 2017; 8(35): 59455 doi: 10.18632/oncotarget.19755
7
Joseph Asemota, Olubunmi Oladunjoye, Atinuke Babalola, Ugonna Nwosu, Po-Hong S Liu, Adeolu O Oladunjoye, Nelsy Castro-Webb, Rebecca A Miksad. Comparison of Hepatocellular Carcinoma in Hispanics and Non-Hispanics PatientsCureus 2021;  doi: 10.7759/cureus.14884
8
Joseph Asemota, Mohammed Saleh, Osato Igbinovia, Danny Burns. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular CarcinomaCureus 2020;  doi: 10.7759/cureus.9191
9
L.A. Caicedo, A. Delgado, M. Duque, D.F. Jiménez, M. Sepulveda, J.A. García, L.S. Thomas, V.H. Garcia, A.M. Aristizabal, C. Gomez, A.M. Arrunategui, E. Manzi, M. Millan, J.I. Villegas, O. Serrano, A. Holguín, G.J. Echeverri. Tumor Biology as Predictor of Mortality in Liver Transplantation for Hepatocellular CarcinomaTransplantation Proceedings 2018; 50(2): 485 doi: 10.1016/j.transproceed.2017.11.040
10
Hae Won Lee, Gi‐Won Song, Sung‐Gyu Lee, Jong Man Kim, Jae‐Won Joh, Dai Hoon Han, Soon Il Kim, Seong Hoon Kim, Dong‐Sik Kim, Jai Young Cho, Kyung‐Suk Suh. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular CarcinomaLiver Transplantation 2018; 24(9): 1243 doi: 10.1002/lt.25056
11
Luis D. Boada, L.A. Henríquez-Hernández, O.P. Luzardo. The impact of red and processed meat consumption on cancer and other health outcomes: Epidemiological evidencesFood and Chemical Toxicology 2016; 92: 236 doi: 10.1016/j.fct.2016.04.008
12
Weisheng Guo, Lin Zhao, Guangya Wei, Peng Liu, Yu Zhang, Liran Fu. <p>Circ_0015756 Aggravates Hepatocellular Carcinoma Development by Regulating FGFR1 via Sponging miR-610</p>Cancer Management and Research 2020; : 7383 doi: 10.2147/CMAR.S262231
13
Reza Arefnezhad, Sara Ashna, Fatemeh Rezaei‐Tazangi, Seyed Mahdi Arfazadeh, Seyede Shabnam Seyedsalehie, Shaghayegh Yeganeafrouz, Melika Aghaei, Mandana Sanandaji, Ramin Davoodi, Sareh Ranjbar Karim Abadi, Massoud Vosough. Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rateCell Biology International 2024; 48(5): 556 doi: 10.1002/cbin.12145